MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 201 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q3 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,662,603 | -44.3% | 266,260 | -30.8% | 0.01% | -44.4% |
| Q2 2023 | $4,784,212 | -43.5% | 384,892 | -36.3% | 0.02% | -47.1% |
| Q1 2023 | $8,462,661 | -32.0% | 604,044 | -30.5% | 0.03% | -37.0% |
| Q4 2022 | $12,439,986 | -38.2% | 869,321 | +10.3% | 0.05% | -41.3% |
| Q3 2022 | $20,124,000 | +2.3% | 788,244 | +13.9% | 0.09% | +5.7% |
| Q2 2022 | $19,665,000 | -21.3% | 692,199 | -2.3% | 0.09% | -1.1% |
| Q1 2022 | $24,985,000 | -16.3% | 708,400 | -0.6% | 0.09% | -6.4% |
| Q4 2021 | $29,864,000 | -48.0% | 712,748 | -39.0% | 0.09% | -51.8% |
| Q3 2021 | $57,388,000 | +41.4% | 1,169,280 | +20.2% | 0.20% | +38.3% |
| Q2 2021 | $40,588,000 | +123.0% | 972,630 | +90.5% | 0.14% | +104.3% |
| Q1 2021 | $18,199,000 | +1863.2% | 510,630 | +1444.8% | 0.07% | +2200.0% |
| Q4 2020 | $927,000 | – | 33,054 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $216,810,330 | 13.15% |
| 12 West Capital Management LP | 6,463,111 | $64,631,110 | 5.85% |
| Alpine Peaks Capital, LP | 359,300 | $3,593,000 | 2.50% |
| Connacht Asset Management LP | 24,155 | $241,550 | 1.43% |
| QVIDTVM Management LLC | 163,230 | $1,632,300 | 1.27% |
| BRAIDWELL LP | 3,974,857 | $39,748,570 | 1.26% |
| Mesirow Institutional Investment Management, Inc. | 926,277 | $9,262,770 | 0.94% |
| Granite Investment Partners, LLC | 1,488,359 | $14,883,590 | 0.62% |
| CARLSON CAPITAL L P | 635,000 | $6,350,000 | 0.50% |
| Pier Capital, LLC | 290,563 | $2,905,630 | 0.47% |